A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines-Reference-Cited by-同舟云学术

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines

Published:2019-04-23 Issue:10 Volume:15 Page:2491-2500
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Findlow Jamie¹,Balmer Paul²,Borrow Ray³

Affiliation:

1. Vaccines, Medical and Scientific Affairs, International Developed Markets, Pfizer Ltd, Surrey, UK

2. Vaccine Medical and Scientific Affairs, Pfizer Inc, Collegeville, PA, USA

3. Public Health England, Manchester Royal Infirmary, Manchester, UK

Funder

Pfizer Inc

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1593082

Reference97 articles.

1. Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management

2. European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases. [accessed 2017 Aug 15]. https://ecdc.europa.eu/en/surveillance-atlas-infectious-diseases.

3. Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report. 2016. [accessed 2017 Nov 29]. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf.

4. Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report. 2015. [accessed 2018 June 19]. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2015.pdf.

5. European Centre for Disease Prevention and Control. Annual epidemiological report for 2015: invasive meningococcal disease. [accessed 2018 Oct 11]. https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-meningococcal-disease.pdf.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study;Infectious Diseases and Therapy;2024-07-02

2. Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination;Expert Review of Vaccines;2024-06-07

3. Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV;Microorganisms;2023-12-23

4. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial;The Lancet Infectious Diseases;2023-12

5. Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older;Infectious Diseases and Therapy;2023-09-27